The bone growth therapies unit was under Orthofix’s spine segment, according to a Feb. 29 news release. As part of realignment bone growth therapies will be managed by Mr. Shallenberger, and spine will be managed under another president.
Mr. Shallenberger was previously vice president of U.S. sales and marketing for bone growth therapies. He joined the company in 2005 as a territory manager and held various leadership positions with the company.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
